Asthra AI — Field notes from the regulated-writing frontier https://www.asthra-writer.ai Articles and analysis from the Asthra team on AI in regulated writing, provenance, citation graphs, and the regulatory landscape. en-us Sat, 02 May 2026 00:00:00 GMT First PROTAC Approval Rewrites the Regulatory Playbook for Degraders https://www.asthra-writer.ai/blog/first-protac-approval-rewrites-the-regulatory-playbook-for-degraders https://www.asthra-writer.ai/blog/first-protac-approval-rewrites-the-regulatory-playbook-for-degraders Sat, 02 May 2026 00:00:00 GMT FDA's approval of vepdegestrant establishes the first regulatory precedent for PROTAC protein degraders, creating a framework that will shape development strategies across the emerging degrader landscape. Industry Analysis guru@asthra-writer.ai (Asthra AI Team) FDA's First Non-Antipsychotic Dementia Agitation Approval Changes Treatment Paradigm https://www.asthra-writer.ai/blog/fda-s-first-non-antipsychotic-dementia-agitation-approval-changes-treatment-para https://www.asthra-writer.ai/blog/fda-s-first-non-antipsychotic-dementia-agitation-approval-changes-treatment-para Fri, 01 May 2026 00:00:00 GMT FDA approves Auvelity for Alzheimer's agitation, marking a breakthrough in dementia care. We analyze the regulatory pathway, novel endpoints, and what this means for CNS drug development. Industry Analysis guru@asthra-writer.ai (Asthra AI Team) Kymera's KT-621 Fast Track: What Degrader Designations Signal for Respiratory Programs https://www.asthra-writer.ai/blog/kymera-s-kt-621-fast-track-what-degrader-designations-signal-for-respiratory-pro https://www.asthra-writer.ai/blog/kymera-s-kt-621-fast-track-what-degrader-designations-signal-for-respiratory-pro Fri, 01 May 2026 00:00:00 GMT FDA grants Fast Track to Kymera's IRAK4 degrader KT-621 for eosinophilic asthma. We analyze what this designation reveals about regulatory pathways for targeted protein degradation in respiratory disease. Industry Analysis guru@asthra-writer.ai (Asthra AI Team) When Partnerships End, Documentation Inheritance Becomes a Regulatory Burden https://www.asthra-writer.ai/blog/when-partnerships-end-documentation-inheritance-becomes-a-regulatory-burden https://www.asthra-writer.ai/blog/when-partnerships-end-documentation-inheritance-becomes-a-regulatory-burden Fri, 01 May 2026 00:00:00 GMT Big pharma partnership terminations leave smaller biotechs holding jointly-authored documents that need sponsor re-issue. The regulatory writing burden of these terminations is rarely discussed but significant. Industry Analysis guru@asthra-writer.ai (Asthra AI Team) Writer-Defined Provenance: Why Source Control Matters in AI-Assisted Regulatory Writing https://www.asthra-writer.ai/blog/writer-defined-provenance-in-ai-regulatory-writing https://www.asthra-writer.ai/blog/writer-defined-provenance-in-ai-regulatory-writing Tue, 15 Jul 2025 00:00:00 GMT How writer-defined provenance ensures that every piece of AI-generated regulatory content is traceable to its specific source document, section, table, or image. Technology guru@asthra-writer.ai (Asthra AI Team) What Is Regulatory Writing Automation in Life Sciences? https://www.asthra-writer.ai/blog/what-is-regulatory-writing-automation https://www.asthra-writer.ai/blog/what-is-regulatory-writing-automation Tue, 01 Jul 2025 00:00:00 GMT A clear definition of regulatory writing automation: what it covers, which documents benefit most, and why the life sciences industry is adopting AI-assisted drafting now. Fundamentals guru@asthra-writer.ai (Asthra AI Team) CSR Timelines: From One Month to Less Than 10 Days https://www.asthra-writer.ai/blog/csr-timelines-from-one-month-to-less-than-ten-days https://www.asthra-writer.ai/blog/csr-timelines-from-one-month-to-less-than-ten-days Sun, 15 Jun 2025 00:00:00 GMT How AI-assisted drafting is compressing Clinical Study Report timelines from weeks of manual effort to days of focused writing, without compromising quality or traceability. Use Cases guru@asthra-writer.ai (Asthra AI Team)